Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery
暂无分享,去创建一个
A. S. Sobolev | R. Schiffelers | A. A. Rosenkranz | Y. V. Khramtsov | T. A. Slastnikova | P. Gulak | T. N. Lupanova | M. Zalutsky
[1] E. Kim. Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer , 2011, The Journal of Nuclear Medicine.
[2] V. Tolmachev,et al. Use of a HEHEHE purification tag instead of a hexahistidine tag improves biodistribution of affibody molecules site-specifically labeled with (99m)Tc, (111)In, and (125)I. , 2011, Journal of medicinal chemistry.
[3] Britton Chance,et al. Evaluation of bacteriochlorophyll-reconstituted low-density lipoprotein nanoparticles for photodynamic therapy efficacy in vivo. , 2011, Nanomedicine.
[4] R. Jain,et al. Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.
[5] S. Nie,et al. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. , 2010, ACS nano.
[6] M. Pautler,et al. Nanomedicine: promises and challenges for the future of public health , 2010, International journal of nanomedicine.
[7] James H. Adair,et al. Nanoparticulate alternatives for drug delivery. , 2010, ACS nano.
[8] A. Kassis,et al. Targeted Auger Electron Radiotherapy of Malignancies , 2010 .
[9] Borries Demeler,et al. Assembly Mechanism of the Sixty-Subunit Nanoparticles via Interaction of RNA with the Reengineered Protein Connector of phi29 DNA-Packaging Motor , 2010, ACS nano.
[10] A. Chilkoti,et al. Morphing low-affinity ligands into high-avidity nanoparticles by thermally triggered self-assembly of a genetically encoded polymer. , 2010, ACS nano.
[11] Michael Schmidt,et al. Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. , 2010, ACS nano.
[12] Ingo Köper,et al. Reusable localized surface plasmon sensors based on ultrastable nanostructures. , 2010, Small.
[13] Mark E. Davis,et al. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles , 2009, Proceedings of the National Academy of Sciences.
[14] R. Mahato,et al. Pharmaceutical perspectives of cancer therapeutics , 2009 .
[15] Michael M. Schmidt,et al. A modeling analysis of the effects of molecular size and binding affinity on tumor targeting , 2009, Molecular Cancer Therapeutics.
[16] G. Miotto,et al. A novel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: in vitro and in vivo studies. , 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[17] P. Couvreur,et al. Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.
[18] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[19] A. S. Sobolev,et al. Engineered modular recombinant transporters: application of new platform for targeted radiotherapeutic agents to alpha-particle emitting 211 At. , 2008, International journal of radiation oncology, biology, physics.
[20] Malini Olivo,et al. Improved formulation of photosensitizer chlorin e6 polyvinylpyrrolidone for fluorescence diagnostic imaging and photodynamic therapy of human cancer. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[21] A. S. Sobolev,et al. Modular drug transporters with diphtheria toxin translocation domain form edged holes in lipid membranes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[22] A. S. Sobolev. Modular transporters for subcellular cell-specific targeting of anti-tumor drugs. , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.
[23] G. Miotto,et al. Tumour-localizing and -photosensitising properties of meso-tetra(4-nido-carboranylphenyl)porphyrin (H2TCP). , 2007, Journal of photochemistry and photobiology. B, Biology.
[24] Wolfgang A. Weber,et al. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging , 2007, Proceedings of the National Academy of Sciences.
[25] T. Hasan,et al. Strategies for Enhanced Photodynamic Therapy Effects † , 2007, Photochemistry and photobiology.
[26] R. Reilly,et al. 111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2/neu-Amplified Breast Cancer , 2007, Journal of Nuclear Medicine.
[27] H. Mojzisova,et al. The pH-dependent distribution of the photosensitizer chlorin e6 among plasma proteins and membranes: a physico-chemical approach. , 2007, Biochimica et biophysica acta.
[28] A. Wu,et al. Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: optimal pharmacokinetics for therapy. , 2007, Cancer research.
[29] A. S. Sobolev,et al. Targeting cancer cells by novel engineered modular transporters. , 2006, Cancer research.
[30] M. Zalutsky,et al. Preparation of N-succinimidyl 3-[*I]iodobenzoate: an agent for the indirect radioiodination of proteins , 2006, Nature Protocols.
[31] U. Nielsen,et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. , 2006, Cancer research.
[32] A. Saito,et al. Footpad reaction induced by Neospora caninum tachyzoite extract in infected BALB/c mice. , 2006, Veterinary parasitology.
[33] Paul Chen,et al. Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[34] J. Richie,et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[35] S. Emanuel,et al. The in vitro and in vivo effects of JNJ-7706621: a dual inhibitor of cyclin-dependent kinases and aurora kinases. , 2005, Cancer research.
[36] H. Benson,et al. Comparison of Diafiltration and Tangential Flow Filtration for Purification of Nanoparticle Suspensions , 2005, Pharmaceutical Research.
[37] A. S. Sobolev,et al. Recombinant modular transporters on the basis of epidermal growth factor for targeted intracellular delivery of photosensitizers , 2005, Current Research on Laser Use in Oncology.
[38] Stanley B. Brown,et al. The present and future role of photodynamic therapy in cancer treatment. , 2004, The Lancet. Oncology.
[39] J. Reubi. Peptide receptors as molecular targets for cancer diagnosis and therapy. , 2003, Endocrine reviews.
[40] A. S. Sobolev,et al. Recombinant modular transporters for cell‐specific nuclear delivery of locally acting drugs enhance photosensitizer activity , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[41] O. Larsson,et al. Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker , 2002, British Journal of Cancer.
[42] D. Görlich,et al. The permeability barrier of nuclear pore complexes appears to operate via hydrophobic exclusion , 2002, The EMBO journal.
[43] M. Bombaci,et al. Identification and Cloning of a Cryptococcal Deacetylase That Produces Protective Immune Responses , 2002, Infection and Immunity.
[44] J. Kublin,et al. Delayed-type hypersensitivity in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites. , 2002, Vaccine.
[45] N. Pante,et al. Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm. , 2002, Molecular biology of the cell.
[46] E. Conti,et al. Nucleocytoplasmic transport enters the atomic age. , 2001, Current opinion in cell biology.
[47] G. Wilson,et al. In vivo targeting of malignant melanoma by 125Iodine- and 99mTechnetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[48] J. Moan,et al. Increased binding of chlorin e6 to lipoproteins at low pH values. , 2000, The international journal of biochemistry & cell biology.
[49] P. Chowienczyk,et al. LDL particle size: an important drug target? , 1999, British journal of clinical pharmacology.
[50] J. Wikberg,et al. Melanocortin receptors: perspectives for novel drugs. , 1999, European journal of pharmacology.
[51] D. Kessel,et al. Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin. , 1998, Journal of Investigative Dermatology.
[52] R. Jain,et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[53] A. S. Sobolev,et al. Nuclear Targeting of Chlorin e6 Enhances Its Photosensitizing Activity* , 1997, The Journal of Biological Chemistry.
[54] A. S. Sobolev,et al. Modification of fluid lipid and mobile protein fractions of reticulocyte plasma membranes affects agonist-stimulated adenylate cyclase. Application of the percolation theory. , 1995, Biochimica et biophysica acta.
[55] D. Jocham,et al. Tumour localisation kinetics of photofrin and three synthetic porphyrinoids in an amelanotic melanoma of the hamster. , 1993, British Journal of Cancer.
[56] E. Gautherot,et al. Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice. , 1990, Cancer research.
[57] A. Eberle,et al. Characterization of Receptors for α-Melanocyte-stimulating Hormone on Human Melanoma Cells , 1989 .
[58] A. Macgillivray. ELISA and other solid phase immunoassays: Theoretical and practical aspects , 1989 .
[59] T. Delaney,et al. Photodynamic therapy of cancer. , 1988, Comprehensive therapy.
[60] W. Wilson,et al. A semiautomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells. , 1984, Analytical biochemistry.
[61] 郑俊海,et al. 科技期刊稿件处理的精细化管理——《International Journal of Nanomedicine〉〉投稿体会 , 2014 .
[62] H. Maeda,et al. Tumor-Targeted Macromolecular Drug Delivery Based on the Enhanced Permeability and Retention Effect in Solid Tumor , 2009 .
[63] John M. Walker,et al. The Protein Protocols Handbook , 2009, Springer Protocols Handbooks.
[64] Andrew J Racher,et al. Antibody production. , 2006, Advanced drug delivery reviews.
[65] A. S. Sobolev,et al. Targeted intracellular delivery of photosensitizers. , 2000, Progress in biophysics and molecular biology.
[66] John M. Walker,et al. The Protein Protocols Handbook , 1996, Humana Press.
[67] S. Challacombe,et al. ELISA and other solid phase immunoassys : theoretical and practical aspects , 1988 .